Product name : Trabectedin Catalog No. : HY-50936 CAS No. : 114899-77-3 1.2 Relevant identified uses of the substance or mixture and uses advised against Identified uses : Laboratory chemicals, manufacture of substances. 1.3 Details of the supplier of the safety data sheet Company: MedChemExpress USA Tel: 609-228-6898 Fax: 609-228-5909 SpletTrabectedin has potent antitumor activity and the potential for soft tissue sarcoma and ovarian cancer research. Trabectedin inhibits cell growth of MX-1, MCF7 and MCF7/DXR …
Did you know?
SpletAbstract Introduction: Trabectedin, a marine-derived DNA-binding antineoplastic agent, has been registered by the EMA and recently also by the FDA for the treatment of patients with advanced soft-tissue sarcoma (STS), a rare and heterogeneous disease. SpletTrabectedin Catalog No. T17155 CAS 114899-77-3 Synonyms: ET 743, Ecteinascidin743, Ecteinascidin 743, inhibit, ROS, Inhibitor, Trabectedin, backbone, Ecteinascidin-743, Cytotoxicity, tetrahydroisoquinoline, superoxides, ET743, DNA, Apoptosis, ET-743, alkaloid, cell-cycle, anti-inflammatory, antitumor, Reactive Oxygen Species
SpletTrabectedin is the generic name for the trade name drug Yondelis®. In some cases health care professionals may use the trade name Yondelis® when referring to the generic drug name trabectedin. Drug Type: Trabectedin is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Trabectedin is classified as an "alkylating agent." SpletTrabectedin Intermediate A24 308359-33-3 Chemsrc provides Trabectedin(CAS#:1144899-77-3) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of Trabectedin are included as well. >> amp version: Trabectedin
SpletProduct name : trabectedin intermediate CBnumber : CB33166191 CAS : 236743-98-9 Synonyms : Trabectedin Intermediate Relevant identified uses : For R&D use only. Not for … Splet28. maj 2024 · 艾日布林是由卫材内部发现和开发，是一种抗肿瘤药物，化学式:c40h59no11,分子量:729.916,msds。 艾日布林的作用机制是什么？ 艾日布林的作用机制：艾日布林通过直接与微管蛋白结合抑制有丝分裂，通过抑制微管生长，抑制癌细胞生长而发挥治疗作用。
SpletTrabectedin (Ecteinascidin 743; ET-743) is a tetrahydroisoquinoline alkaloid with potent antitumor activity. Trabectedin binds to the minor groove of DNA, blocks transcription of …
Splet13. jul. 2015 · During a fire, irritating and highly toxic gases may be generated by thermal decomposition orcombustion.Extinguishing Media:In case of fire, use water, dry … mmvta websiteSpletTrabectedin, sold under the brand name Yondelis, is an antitumor chemotherapy medication for the treatment of advanced soft-tissue sarcoma and ovarian cancer. [3] [4] The most common adverse reactions include nausea, fatigue, vomiting, constipation, decreased appetite, diarrhea, peripheral edema, dyspnea, and headache. [3] [4] mm vs footSpletDin 333 de paciente cu cancer ovarian cărora li s-a administrat trabectedin în asociere cu DLP, 24% au avut vârsta de 65 de ani sau peste și 6% au avut vârsta peste 75 de ani. Nu au fost observate diferențe relevante privind profilul de siguranță pentru această grupă de pacienți. Se pare că clearance-ul mmv vehicleSplet23. feb. 2024 · Chemsrc provides Trabectedin Intermediate(CAS#:2291328-15-7) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of Trabectedin Intermediate are included as well. mmv wohnmobilSplet24. feb. 2010 · There is a simple discount patient access scheme for trabectedin. Contact [email protected] or phone 07824 345 045 for details. Guidance development process How we develop NICE technology appraisal guidance Your … mmv montchavinSplet14. jan. 2024 · Trabectedin (Ecteinascidin-743 or ET-743) is a novel antitumour agent of marine origin with potent antitumour activity both in vitro and in vivo.IC50 Value: 0.1-3.7 … mmvw softwareSplet24. feb. 2010 · Evidence-based recommendations on trabectedin (Yondelis) for treating advanced soft tissue sarcoma in adults. In February 2024 we updated sections 1 and 2 of … mmv year